bpc-157 clinical trials dosing dosage BPC-157 (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or BPC-157: Benefits & Dosage Guide
Description
Baseline labs (with IGF-1 for growth hormone peptides) and periodic re-checks are how a clinician doses safely and tracks whether a protocol is working
The evidence picture for BPC-157 reminds me of many natural compounds that eventually proved beneficial in clinical trials after decades of traditional use
Blood (2017) 129:3294303
Registered Nurse (RN) administers 1000 mcg Vitamin B12 intramuscularly (IM) in left upper arm
Chronic tendinopathy this is where the actin-mediated rationale is most interesting in theory: chronic tendinopathy involves fibroblast dysfunction, and a cell-migration mechanism is proposed to address that differently than pure growth-factor approaches
